Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

NCT02261116 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Telmisartan
DRUG: Candesartan
DRUG: Placebo

Sponsor

Boehringer Ingelheim